Publication by Zufferey et al. in Joint Bone & Spine
In this study, the authors report that in Switzerland, Rheumatoid Arthritis patients are initiated on biologics at lower disease activity (DAS28-ESR of 4.4) than in other European countries. One year after treatment, the DAS28 dropped to an average of 3.3 and 27% reached remission. Click here to read more....
